New Products

EMERYVILLE, Calif. — LeapFrog Enterprises, which specializes in educational entertainment for children, on Thursday announced the introduction of LeapBand, the first wearable activity tracker designed for kids that encourages active play and healthy habits.

BOCA RATON, Fla. — Empowering its customers with new ways to manage their health, MobileHelp — a provider of mobile Personal Emergency Response System solutions — has launched a new medication reminder application.

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday granted approval to Zykadia (ceritinib) for patients with a specific type of late-stage (metastatic) non-small cell lung cancer (NSCLC).

The drug — an anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor — blocks proteins that promote the development of cancerous cells and is intended for patients with metastatic ALK-positive NSCLC who were previously treated with crizotinib.

BROOMFIELD, Colo. — Horizon, a national organic dairy brand, on Tuesday announced the launch of a line of new snack products, which include Horizon Snack Crackers, Sandwich Crackers and Snack Grahams. These items are part of the company's journey outside of the dairy case and come on the heels of several Mac & Cheese products in January.

SOMERSET, N.J. — Tic Tac mints, a brand from the Ferrero Co., on Tuesday announced the debut of limited edition Summer Ice Pop Tic Tac mints. The combination of blue berry-flavored pills, red cherry-flavored pills and white lime-flavored pills aims to offer consumers a nostalgic reminder of summertime, the company said.

AIRPORT CITY, Israel — SodaStream, a manufacturer and distributor of home beverage carbonation systems, last week announced SodaStream Free, a range of fruit-flavored syrup concentrates that allows consumers to make beverages at home. These syrups contain a fraction of the calories and sugar content of regular soft drinks, the company said.

 

UTTAR PRADESH, India — Jubilant Life Sciences, an integrated pharmaceuticals and life sciences company, last week announced that it received approval from the Food and Drug Administration for spironolactone tablets, 25 mg, 50 mg and 100 mg, which is the generic version of Aldactone. The drug is used to treat fluid retention caused by congestive heart failure and cirrhosis of the liver.

The market size for spironolactone tablets is $87 million per annum, according to IMS data. The company said it expects to launch the product in first quarter 2015.

MINNEAPOLIS — Effective May 5, Bob DeRodes will lead Target’s information technology transformation as EVP and chief information officer, as the retailer continues to recover from the data breach late last year.

Target also provided details on additional security enhancements it has made following that breach — which reportedly resulted in the theft of 40 million credit and debit card records and 70 million other records of customer details — and shared plans to incorporate MasterCard chip-and-PIN technology across its REDcard portfolio.